AGT and diabetic kidney disease: Advanced glycation end products (AGE) could cause podocyte DNA injury and detachment partly through stimulation of Ang II-AT1R axis, thus supplying a innovative beneficial feature of telmisartan in DKD (Fukami et al., 2013).